Working... Menu

Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medically Refractory Primary Cervical Dystonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00148889
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : February 16, 2018
Competence Network on Parkinson's Disease
Information provided by (Responsible Party):
German Parkinson Study Group (GPS)

Brief Summary:
The purpose of this study is to investigate the efficacy and safety of bilateral pallidal stimulation in patients with medically refractory primary cervical dystonia.

Condition or disease Intervention/treatment Phase
Cervical Dystonia Device: Deep brain stimulation (DBS) Phase 3

Detailed Description:

Primary cervical dystonia (CD) affects about 20-40/100.000 population. The disease is chronic and life-long. The therapy of choice are local intramuscular Botulinum Toxin injections given every three months. Oral medication such as anticholinergics or dopamine depleting drugs are usually of limited efficacy or their use is limited by intolerable side-effects. About 5-10% of CD patients develop neutralizing antibodies against Botulinum Toxin. Two previous controlled multicenter trials have shown the efficacy and safety of bilateral pallidal stimulation in patients with primary segmental and generalized dystonia (one study was performed by our group).

Following surgery, patients will be randomized 1:1 to verum or placebo stimulation for a period of three months. Primary outcome measure is the TWSTRS (Toronto Western Spasmodic Torticollis Rating Scale) - a validated and widely accepted physician-based outcome measure for cervical dystonia. The independent TWSTRS raters are movement disorders specialists unaware of the stimulation status (verum/placebo) and they compare the TWSTRS-score at baseline and 3-months follow-up. Our hypothesis is that stimulated patients will have a significantly better improvement of dystonia as compared to those without stimulation (placebo group).

After the 3-months period, all patients are unblinded and receive continuous effective stimulation by the implanted system. Regular follow-up visits are scheduled every 12 months for 5 years postoperatively to assess the long-term efficacy of pallidal stimulation. Side-effects are assessed in a standardized way and include the assessment of surgery-induced as well as stimulation-induced side-effects.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 63 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Prospective,Randomised, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Bilateral Globus Pallidus Internus - in Patients With Medically Refractory Primary Cervical Dystonia
Study Start Date : July 2005
Actual Primary Completion Date : April 2008
Actual Study Completion Date : April 2008

Arm Intervention/treatment
Sham Comparator: 2
Device: Deep brain stimulation (DBS)
Bilateral pallidal stimulation with an implanted DBS device

Active Comparator: 1
Active GPI-DBS
Device: Deep brain stimulation (DBS)
Bilateral pallidal stimulation with an implanted DBS device

Primary Outcome Measures :
  1. Toronto Western Spasmodic Torticollis Scale (TWSTRS) at 3 months following surgery (comparison between placebo and control group) [ Time Frame: 3 months ]

Secondary Outcome Measures :
  1. side-effects, quality of life, depression, pain, long-term efficacy [ Time Frame: 5 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary cervical dystonia
  • Disease duration 3 years or longer
  • Adult patient (18 years or older)
  • TWSTRS severity score 15 or more
  • Non-response to Botulinum Toxin
  • Non-response to oral antidystonic medication
  • Informed consent

Exclusion Criteria:

  • Dementia (Mattis Dementia Rating Scale below 120)
  • Severe depression (Beck Depression Inventory >25)
  • Previous functional stereotactic surgery
  • Hemidystonia or generalized dystonia
  • Severe brain atrophy
  • Contraindication against surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00148889

Layout table for location information
Medical University Innsbruck, Department of Neurology
Innsbruck, Tyrol, Austria, 6020
Department of Neurosurgery, Medical University Vienna
Vienna, Austria, 1090
Department of Neurology, Charité, Humboldt-University Berlin
Berlin, Germany, 13353
Clinic of Neurosurgery, Medical University Hannover
Hannover, Germany, 30625
Department of Neurology, University Heidelberg
Heidelberg, Germany, 69120
Department of Neurology, University Kiel
Kiel, Germany, 24105
Department for Stereotaxy and Functional Neurosurgery, University Cologne
Köln, Germany, 50937
Department of Neurology, University Regensburg
Regensburg, Germany, 93053
Department of Neurology, University Rostock
Rostock, Germany, 18147
Hertie-Institute for Clinical Brain Research
Tübingen, Germany, 72076
Sponsors and Collaborators
German Parkinson Study Group (GPS)
Competence Network on Parkinson's Disease
Layout table for investigator information
Principal Investigator: Joerg Mueller, MD Department of Neurology, Medical University Innsbruck, Anichstr. 35, A-6020 Innsbruck, Austria

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: German Parkinson Study Group (GPS) Identifier: NCT00148889     History of Changes
Other Study ID Numbers: CD-DBS-2005-JM
First Posted: September 8, 2005    Key Record Dates
Last Update Posted: February 16, 2018
Last Verified: February 2018

Keywords provided by German Parkinson Study Group (GPS):
cervical dystonia
deep brain stimulation
pallidal stimulation
globus pallidus internus

Additional relevant MeSH terms:
Layout table for MeSH terms
Dystonic Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Movement Disorders
Central Nervous System Diseases